U.S. FDA Grants Theradaptive IDE Approval For Phase I/II Clinical Trials
February 22, 2024
READ MORE
3D Systems & Theradaptive Establish Commercial Partnership to Advance Orthopedic & Soft Tissue Repair Using Breakthrough Regenerative Therapeutics
August 8, 2023
READ MORE
Leveraging Material-Binding Recombinant Proteins: A Novel Approach to Tissue Regeneration
April 20, 2023
READ MORE
Unlocking a New Era of Healing: Protein Engineering’s Transformative Impact on Therapeutics – BioTalk
April 3, 2023
READ MORE
U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
March 1, 2023
READ MORE
Revolutionizing Orthopedics: The Transformative Potential of Regenerative Medicine
February 23, 2023
READ MORE
Theradaptive’s Targetable Protein AMP2 Beats Spinal Fusion Standard of Care
February 9, 2023
READ MORE
Why Protein Engineering Is Opening Up New Horizons for Medical Devices By Dr Luis Alvarez
October 26, 2022
READ MORE
Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion
February 15, 2022
READ MORE
Theradaptive closes seed round bringing total investment to $17.4M to date.
January 19, 2021
READ MORE
Theradaptive, Inc. Receives $6.2 Million Infusion of Cash from Seed Funding
January 19, 2021
READ MORE
Governor Hogan announced Maryland’s Future 20, a list of innovative startups. #USAMRDC licensing partner, Theradaptive Inc is among the five life science companies chosen for the list.
January 14, 2021
READ MORE
Frederick biotech Theradaptive raises $6.2M as it heads toward clinical trials
January 14, 2021
READ MORE
Recon: US buys another 100M doses of Pfizer-BioNTech vaccine; AstraZeneca submits vaccine data to MHRA
December 23, 2020
READ MORE
Career Ladder: Luis Alvarez West Point and MIT grad brings his love of chemistry to bear on regenerative medicine
September 1, 2020
READ MORE
These Seed and Early-Stage Investment Funds in Maryland Are Fueling Life Science Startups
August 19, 2020
READ MORE
A Sticky Solution to a Hard Problem : Interview with Dr. Luis Alvarez, CEO of Theradaptive
April 6, 2020
READ MORE
Army veteran’s bone ‘paint’ for wounded warriors nears FDA testing phase
February 20, 2020
READ MORE
‘Paint’ that Purports to Regrow Wounded Troops’ Bones Moving Toward FDA Testing
February 20, 2020
READ MORE
The Alliance for Regenerative Medicine Releases Agenda for 2020 Cell & Gene Meeting on the Mediterranean
February 13, 2020
READ MORE
ORTHOREBIRTH and Theradaptive Enter into License Agreement for THX-14, a Regenerative Treatment Candidate for Trauma with option to extend into Spine Fusion
December 11, 2019
READ MORE
Theradaptive Selected as a Finalist at the 2018 First Coast Innovation Challenge in Boston
April 23, 2019
READ MORE